Literature DB >> 20835744

Revision total hip replacement: predictors of blood loss, transfusion requirements, and length of hospitalisation.

Devendra Mahadevan1, Christopher Challand, Jonathan Keenan.   

Abstract

BACKGROUND: Revision total hip replacement (THR) is associated with increased blood loss and extended hospitalization.
MATERIALS AND METHODS: We reviewed 146 patients who underwent revision THR to identify predictors of blood loss, transfusion requirements, and length of hospitalization.
RESULTS: Blood loss was greater with increasing age and in men. Femoral and dual-component revision and revision of cemented hip components were also associated with greater blood loss. Transfusion requirements were greater in patients who had lower preoperative hemoglobin concentration and in patients undergoing dual-component revision. Length of hospitalization was significantly increased in patients who received transfusion but less in patients who underwent isolated acetabular-component hip revision.
CONCLUSIONS: This study shows significantly greater blood loss in men, older patients, revision surgery of cemented implants, and dual-component revisions. More complex revision surgery and preoperative anemia are clearly associated with increased transfusion requirements and length of hospitalization. Identification and treatment of patients at higher risk of transfusion may guide likely transfusion requirements, shorten the length of hospitalization, and reduce the overall cost of treatment.

Entities:  

Mesh:

Year:  2010        PMID: 20835744      PMCID: PMC2948129          DOI: 10.1007/s10195-010-0105-z

Source DB:  PubMed          Journal:  J Orthop Traumatol        ISSN: 1590-9921


  14 in total

1.  Revision total hip arthroplasty: hospital cost and reimbursement analysis.

Authors:  John F Crowe; Thomas P Sculco; Barbara Kahn
Journal:  Clin Orthop Relat Res       Date:  2003-08       Impact factor: 4.176

2.  Pre-operative predictors of the requirement for blood transfusion following total hip replacement.

Authors:  J Aderinto; I J Brenkel
Journal:  J Bone Joint Surg Br       Date:  2004-09

3.  Predictors of blood loss during total hip replacement surgery.

Authors:  J M Grosflam; E A Wright; P D Cleary; J N Katz
Journal:  Arthritis Care Res       Date:  1995-09

4.  Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery.

Authors:  James R Dunne; Debra Malone; J Kathleen Tracy; Christopher Gannon; Lena M Napolitano
Journal:  J Surg Res       Date:  2002-02       Impact factor: 2.192

5.  A standardized method for calculating blood loss.

Authors:  M E Brecher; T Monk; L T Goodnough
Journal:  Transfusion       Date:  1997-10       Impact factor: 3.157

6.  Incidence and risk factors for allogenic blood transfusion during major joint replacement using an integrated autotransfusion regimen. The Rizzoli Study Group on Orthopaedic Anaesthesia.

Authors:  B Borghi; A Casati
Journal:  Eur J Anaesthesiol       Date:  2000-07       Impact factor: 4.330

7.  The influence of preclinical anaemia on outcome following total hip replacement.

Authors:  E Myers; P O'Grady; P O Grady; A M Dolan
Journal:  Arch Orthop Trauma Surg       Date:  2004-10-29       Impact factor: 3.067

8.  Efficacy of intraoperative blood collection and reinfusion in revision total hip arthroplasty.

Authors:  Jeffrey Zarin; David Grosvenor; David Schurman; Stuart Goodman
Journal:  J Bone Joint Surg Am       Date:  2003-11       Impact factor: 5.284

9.  An audit on the blood transfusion requirements for revision hip arthroplasty.

Authors:  S Sharma; H Cooper; J P Ivory
Journal:  Ann R Coll Surg Engl       Date:  2002-07       Impact factor: 1.891

10.  The predictors of red cell transfusions in total hip arthroplasties.

Authors:  G A Nuttall; P J Santrach; W C Oliver; T T Horlocker; W J Shaughnessy; M E Cabanela; S Bryant
Journal:  Transfusion       Date:  1996-02       Impact factor: 3.157

View more
  13 in total

1.  Intraoperative hemorrhage in revision total hip arthroplasty: a retrospective single-center study.

Authors:  Kana Saito; Yu Kaiho; Toru Tamii; Tadaho Nakamura; Eri Kameyama; Masanori Yamauchi
Journal:  J Anesth       Date:  2019-04-29       Impact factor: 2.078

2.  Complications Are Not Increased With Acetabular Revision of Metal-on-metal Total Hip Arthroplasty.

Authors:  Colin T Penrose; Thorsten M Seyler; Samuel S Wellman; Michael P Bolognesi; Paul F Lachiewicz
Journal:  Clin Orthop Relat Res       Date:  2016-10       Impact factor: 4.176

3.  Do revised hip resurfacing arthroplasties lead to outcomes comparable to those of primary and revised total hip arthroplasties?

Authors:  William Desloges; Isabelle Catelas; Toru Nishiwaki; Paul R Kim; Paul E Beaulé
Journal:  Clin Orthop Relat Res       Date:  2012-11       Impact factor: 4.176

4.  Effectiveness of an autologous transfusion system following cemented and non-cemented revisions of total hip arthroplasty.

Authors:  Nael Hawi; Daniel Oliver Kendoff; Udo Hessling; Carl Haasper; Thorsten Gehrke; Mustafa Citak
Journal:  Int Orthop       Date:  2014-05-11       Impact factor: 3.075

5.  Intravenous tranexamic acid for reducing perioperative blood loss during revision hip arthroplasty: A retrospective study.

Authors:  Qiuru Wang; Releken Yeersheng; Donghai Li; Zhouyuan Yang; Pengde Kang
Journal:  Acta Orthop Traumatol Turc       Date:  2020-09       Impact factor: 1.511

6.  Revision total hip arthroplasty in the United States: national trends and in-hospital outcomes.

Authors:  Brian E Schwartz; Hristo I Piponov; Cory W Helder; William F Mayers; Mark H Gonzalez
Journal:  Int Orthop       Date:  2016-02-01       Impact factor: 3.075

7.  Removal of well-fixed components in femoral revision arthroplasty with controlled segmentation of the proximal femur.

Authors:  Panagiotis Megas; Christos S Georgiou; Andreas Panagopoulos; Antonis Kouzelis
Journal:  J Orthop Surg Res       Date:  2014-12-31       Impact factor: 2.359

8.  Increased risk of complications in patients with hypoalbuminemia undergoing revision total hip arthroplasty.

Authors:  Nicole D Rynecki; Dominick V Congiusta; Michael Fields; Rushi Patel; Michael M Vosbikian; Irfan H Ahmed
Journal:  J Orthop       Date:  2020-03-25

9.  Potential cost saving of Epoetin alfa in elective hip or knee surgery due to reduction in blood transfusions and their side effects: a discrete-event simulation model.

Authors:  Jörg Tomeczkowski; Sean Stern; Alfred Müller; Christian von Heymann
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

10.  Predicting length of stay from an electronic patient record system: a primary total knee replacement example.

Authors:  Evelene M Carter; Henry W W Potts
Journal:  BMC Med Inform Decis Mak       Date:  2014-04-04       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.